• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服免疫疗法相关家长负担量表的编制

Development of an Oral Immunotherapy-Related Parental Burden Scale.

作者信息

Maeta Akihiro, Takaoka Yuri, Hamada Masaaki, Nakano Atsuko, Sumimoto Shinichi, Anzai Kaori, Tanaka Yukiko, Morikawa Satoru, Kameda Makoto, Takahashi Kyoko

机构信息

Department of Food Science and Nutrition, School of Food Science and Nutrition, Mukogawa Women's University, Nishinomiya, Japan.

Department of Pediatrics, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, Osaka, Japan.

出版信息

Int Arch Allergy Immunol. 2023;184(12):1203-1215. doi: 10.1159/000533332. Epub 2023 Aug 30.

DOI:10.1159/000533332
PMID:37647864
Abstract

INTRODUCTION

Oral immunotherapy (OIT) imposes a burden on parents and their children with food allergies (FAs). We already developed a questionnaire for OIT-related Parental Burden (OIT-PB) scale. However, the previous questionnaire had some problems. This study modified OIT-PB and verified its reliability and validity.

METHODS

A 20-item draft covering the physical and mental burdens caused by OIT was prepared jointly with multiple allergists. The Food Allergy Quality of Life Questionnaire-Parental Burden (FAQLQ-PB) and Stress Response Scale-18 (SRS-18) were used to verify concurrent validity. A questionnaire survey was administered during treatment to parents of FA children who had started OIT for the first time. An additional OIT-PB survey was performed at one specific institution 1 week after the posttreatment survey.

RESULTS

The responses of 64 of the 76 recruited parents were analyzed. Of the 20 questions, 1 item was excluded owing to the floor effect, 1 was excluded because its commonality was less than 0.2, and 2 were excluded because their factor loading values were less than 0.4. Factor analysis was used to classify the OIT-PB into the following 4 subscales: "burden caused by adherence to treatment plan," "anxiety about symptom-induced risk," "burden due to patient's eating behavior," and "anxiety about treatment effect." The Cronbach's α for all 16 items of the OIT-PB was 0.893; Cronbach's α for each subscale was 0.876, 0.898, 0.874, and 0.717. The re-test reliability coefficient was 0.864 (95% confidence interval [CI]: 0.720-0.937, p < 0.001). A significant positive correlation was found between the OIT-PB and FAQLQ-PB (R = 0.610 [95% CI: 0.422-0.747], p < 0.001) and the SRS-18 (R = 0.522 [95% CI: 0.306-0.687], p < 0.001). A significant negative correlation was found between the rate of increase in OIT food intake and the "anxiety about treatment effect" score (R = -0.355 [95% CI: -0.558-0.112], p < 0.001). Parents of children on the hen's egg OIT treatment scored higher on the "burden due to patient's eating behavior" subscale than did parents of children on the milk and wheat OIT treatment.

CONCLUSION

The burden of OIT experienced by parents can be broadly classified into four categories. The modified OIT-PB was able to evaluate them individually and was shown to have reliability and validity. This scale is expected to be useful in the development of OIT that considers not only therapeutic effect but also the burden experienced by FA children and their parents.

摘要

引言

口服免疫疗法(OIT)给患有食物过敏(FA)的儿童及其父母带来了负担。我们已经开发了一份关于OIT相关父母负担(OIT-PB)量表的问卷。然而,之前的问卷存在一些问题。本研究对OIT-PB进行了修改,并验证了其信效度。

方法

与多位过敏症专科医生共同编制了一份包含20个条目的初稿,涵盖OIT所导致的身心负担。使用食物过敏生活质量问卷-父母负担(FAQLQ-PB)和应激反应量表-18(SRS-18)来验证同时效度。在治疗期间对首次开始OIT的FA儿童的父母进行问卷调查。在治疗后调查1周后,在一个特定机构对同一批父母进行了额外的OIT-PB调查。

结果

对招募的76位父母中的64位的回答进行了分析。在20个问题中,1个问题因地板效应被排除,1个问题因共同性小于0.2被排除,2个问题因因子载荷值小于0.4被排除。采用因子分析将OIT-PB分为以下4个分量表:“遵循治疗计划导致的负担”、“对症状诱发风险的焦虑”、“因患者饮食行为导致的负担”以及“对治疗效果的焦虑”。OIT-PB所有16个条目的克朗巴哈α系数为0.893;每个分量表的克朗巴哈α系数分别为0.876、0.898、0.874和0.717。重测信度系数为0.864(95%置信区间[CI]:0.720 - 0.937,p < 0.001)。发现OIT-PB与FAQLQ-PB(R = 0.610 [95% CI:0.422 - 0.747],p < 0.001)以及SRS-18(R = 0.522 [95% CI:0.306 - 0.687],p < 0.001)之间存在显著正相关。发现OIT食物摄入量的增加率与“对治疗效果的焦虑”得分之间存在显著负相关(R = -0.355 [95% CI:-0.558 - 0.112],p < 0.001)。接受鸡蛋OIT治疗的儿童的父母在“因患者饮食行为导致的负担”分量表上的得分高于接受牛奶和小麦OIT治疗的儿童的父母。

结论

父母所经历的OIT负担可大致分为四类。修改后的OIT-PB能够分别对这些负担进行评估,并显示出具有信效度。该量表有望在开发不仅考虑治疗效果,还考虑FA儿童及其父母所经历负担的OIT中发挥作用。

相似文献

1
Development of an Oral Immunotherapy-Related Parental Burden Scale.口服免疫疗法相关家长负担量表的编制
Int Arch Allergy Immunol. 2023;184(12):1203-1215. doi: 10.1159/000533332. Epub 2023 Aug 30.
2
Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective.8至12岁接受食物过敏口服免疫疗法儿童的生活质量:儿童及家长视角
Allergy. 2020 Oct;75(10):2623-2632. doi: 10.1111/all.14350. Epub 2020 May 22.
3
Psychological Distress and Perceived Burden in Parents of Korean Children With IgE-Mediated Food Allergy.父母心理困扰与韩国 IgE 介导食物过敏儿童感知负担
J Korean Med Sci. 2023 Jul 10;38(27):e208. doi: 10.3346/jkms.2023.38.e208.
4
Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.食物过敏患者口服免疫治疗前后的生活质量。
J Allergy Clin Immunol Pract. 2019 Feb;7(2):429-436.e2. doi: 10.1016/j.jaip.2018.06.016. Epub 2018 Jul 7.
5
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.口服免疫治疗的初始加量阶段可改善食物过敏儿童父母的生活质量和心理负担。
Allergy Asthma Proc. 2024 Mar 1;45(2):128-136. doi: 10.2500/aap.2024.45.240001.
6
Patient quality of life following induction of oral immunotherapy for food allergy.食物过敏口服免疫治疗诱导后的患者生活质量
Pediatr Allergy Immunol. 2016 May;27(3):263-8. doi: 10.1111/pai.12528. Epub 2016 Jan 21.
7
Effectiveness and Safety of Double-Blind, Placebo-Controlled, Low-Dose Oral Immunotherapy with Low Allergen Egg-Containing Cookies for Severe Hen's Egg Allergy: A Single-Center Analysis.双盲、安慰剂对照、低剂量含低变应原鸡蛋饼干口服免疫治疗严重鸡蛋过敏的有效性和安全性:单中心分析。
Int Arch Allergy Immunol. 2019;180(4):244-249. doi: 10.1159/000502956. Epub 2019 Oct 2.
8
Medical clown support is associated with better quality of life of children with food allergy starting oral immunotherapy.医疗小丑支持与儿童食物过敏开始口服免疫治疗时的生活质量改善有关。
Pediatr Allergy Immunol. 2021 Jul;32(5):1029-1037. doi: 10.1111/pai.13445. Epub 2021 Mar 9.
9
Changes in patient quality of life during oral immunotherapy for food allergy.食物过敏口服免疫治疗期间患者生活质量的变化。
Allergy. 2017 Dec;72(12):1883-1890. doi: 10.1111/all.13211. Epub 2017 Jun 15.
10
Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.家长和儿童对随机对照花生口服免疫治疗试验中生活质量的感知。
Pediatr Allergy Immunol. 2019 Sep;30(6):638-645. doi: 10.1111/pai.13066. Epub 2019 Jul 25.